Explore the complete record of transactions filed by Erik Kullgren, 首席财务官. Director active across 2 companies, notably Alzinova AB. Cumulatively, 5 disclosures have been published. History available since 2 April 2025. The latest transaction was disclosed on 1 April 2026 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Erik Kullgren is the Chief Financial Officer of Alzinova AB, a company specializing in the development of treatments for neurodegenerative diseases. In his role, he is responsible for financial management and the company's financial strategy. Erik has a strong background in the sector, enabling him to contribute effectively to the growth and sustainability of Alzinova. His financial expertise is essential to support the company's strategic objectives.